Efficacy and Safety ofSanGrow Decoction for Patients With Diabetes

MedlinePlus related topics: Blood Sugar Primary Outcome Measures: * Fast glucose and HbA1c change between the baseline and end of study \[ Time Frame: From baseline to 30 and 100 days\] * \[ Designated as safety issue: No \] * Successful rate of blood glucose control (the proportion of patients with HbA1c \<7%) \[ Time Frame: From baseline to 30 days and 100 days\] \[ Designated as safety issue: No \] Secondary Outcome Measures: • To evaluate the change of quality of life in the 1 months by the health questionnaire SF-36 \[ Time Frame: From baseline to month 1 \] \[ Designated as safety issue: No \]